.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Accenture
Harvard Business School
Daiichi Sankyo
Teva
Johnson and Johnson
Merck
Deloitte
Chubb
QuintilesIMS

Generated: December 16, 2017

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Germany Patent: 103 55 461

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Janssen PharmsXARELTOrivaroxabanTABLET;ORAL022406-001Jul 1, 2011RXYesNo► Subscribe► SubscribeYPROPHYLAXIS OF DEEP VEIN THROMBOSIS (DVT)
Janssen PharmsXARELTOrivaroxabanTABLET;ORAL022406-001Jul 1, 2011RXYesNo► Subscribe► SubscribeYREDUCING THE RISK OF STROKE AND SYSTEMIC EMBOLISM
Janssen PharmsXARELTOrivaroxabanTABLET;ORAL022406-001Jul 1, 2011RXYesNo► Subscribe► SubscribeYREDUCTION IN THE RISK OF RECURRENCE OF DEEP VEIN THROMBOSIS (DVT) AND PULMONARY EMBOLISM
Janssen PharmsXARELTOrivaroxabanTABLET;ORAL022406-001Jul 1, 2011RXYesNo► Subscribe► SubscribeYTREATMENT OF DEEP VEIN THROMBOSIS (DVT)
Janssen PharmsXARELTOrivaroxabanTABLET;ORAL022406-001Jul 1, 2011RXYesNo► Subscribe► SubscribeYTREATMENT OF PULMONARY EMBOLISM (PE)
Janssen PharmsXARELTOrivaroxabanTABLET;ORAL022406-002Nov 4, 2011RXYesNo► Subscribe► SubscribeYPROPHYLAXIS OF DEEP VEIN THROMBOSIS (DVT)
Janssen PharmsXARELTOrivaroxabanTABLET;ORAL022406-002Nov 4, 2011RXYesNo► Subscribe► SubscribeYREDUCING THE RISK OF STROKE AND SYSTEMIC EMBOLISM
Janssen PharmsXARELTOrivaroxabanTABLET;ORAL022406-002Nov 4, 2011RXYesNo► Subscribe► SubscribeYREDUCTION IN THE RISK OF RECURRENCE OF DEEP VEIN THROMBOSIS (DVT) AND PULMONARY EMBOLISM
Janssen PharmsXARELTOrivaroxabanTABLET;ORAL022406-002Nov 4, 2011RXYesNo► Subscribe► SubscribeYTREATMENT OF DEEP VEIN THROMBOSIS (DVT)
Janssen PharmsXARELTOrivaroxabanTABLET;ORAL022406-002Nov 4, 2011RXYesNo► Subscribe► SubscribeYTREATMENT OF PULMONARY EMBOLISM (PE)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist